SCHEMBL7050801

SCHEMBL7050801

Cc1ccccc1Cn1c2ccc[c]c2c2c(C(N)=O)cccc21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 3/20 0.43
LMNA P02545 2/20 0.41
HTT P42858 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
HIF1A Q16665 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
ALDH1A1 P00352 3/20 0.39
KDM4E B2RXH2 2/20 0.39
GAA P10253 2/20 0.39
MAPT P10636 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
ATM Q13315 1/20 0.39
PARP1 P09874 1/20 0.38
AURKA O14965 1/20 0.38
RPS6KB1 P23443 1/20 0.38
CD38 P28907 1/20 0.38
MAPK8 P45983 1/20 0.37
NPC1 O15118 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27525757 0.92 PLA2G2A (0.36) PLA2G2ALMNAHTTSMN1; SMN2MEN1
SCHEMBL27507603 0.91 FABP4 (0.40) PLA2G2AMEN1KMT2AALDH1A1KDM4E
SCHEMBL27507583 0.90 PLA2G2A (0.35) PLA2G2ALMNAHTTSMN1; SMN2MEN1
SCHEMBL27506049 0.90 PLA2G2A (0.38) PLA2G2A
SCHEMBL27506380 0.88 PLA2G2A (0.37) PLA2G2APARP1CD38C5AR1
SCHEMBL27539340 0.88 GRIN2B (0.36) PLA2G2ALMNAMEN1KMT2AALDH1A1
SCHEMBL27505596 0.88 ALDH1A1 (0.41) SMN1; SMN2MEN1KMT2AALDH1A1KDM4E
SCHEMBL27530662 0.87 FABP4 (0.35) PLA2G2AMEN1KMT2AALDH1A1KDM4E
SCHEMBL2584590 0.87 PLA2G2A (0.43) PLA2G2APARP1
SCHEMBL7619283 0.86 PLA2G2A (0.42) PLA2G2ALMNAMEN1KMT2AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013067579-A1 ADIPOSITY-MODULATING MOLECULES AND USES THEREFOR THE UNIVERSITY OF QUEENSLAND (AU) 2013-05-16 WO disclosed
CN-102271507-A Secreted phospholipase A2(SPLA2) Inhibitor and niacin pharmaceutical composition and method for treating cardiovascular diseases and dyslipidemia 2011-12-07 CN disclosed
EP-1303262-A2 USE OF A SPLA2 INHIBITOR FOR THE TREATMENT OF SEPSIS ELI LILLY AND COMPANY (US) 2003-04-23 EP disclosed
WO-2002005796-A2 USE OF A SPLA2 INHIBITOR FOR THE TREATMENT OF SEPSIS ELI LILLY AND COMPANY (US) 2002-01-24 WO disclosed
CN-1240210-A Substituted tricyclic compound LILLY CO ELI (US) 2000-01-05 CN disclosed